An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results.
Yong-Rong LaiMaria Domenica CappelliniYesim AydinokJohn PorterZeynep KarakasVip ViprakasitNoppadol SiritanaratkulAntonis KattamisRongrong LiuMiguel IzquierdoJanet LasherSameera GovindarajuAli T TaherPublished in: American journal of hematology (2022)